Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...
The Currentbody LED Hair Growth Helmet uses red light therapy at a wavelength of 660nm, to deeply penetrate into the scalp. This increases blood flow and decreases dihydrotestosterone (DHT) levels, a ...
A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...